No article in the knowledge graph for Opto Circuits (India) Limited yet.
Who is Opto Circuits (India) Limited?
Opto Circuits (India) Limited is a medical technology company focused on the design, manufacture, and marketing of medical devices and monitoring solutions for hospital, emergency, and home-care settings.
- Non-invasive patient monitoring systems and vital signs monitors for clinical and emergency care (medical devices).
- Cardiac and vascular treatment devices, including stents and related interventional products (cardiovascular devices).
- Digital thermometers, blood pressure monitors, and related home-care diagnostic equipment for consumer and institutional use (home health monitoring).
- Original Equipment Manufacturer (OEM) components and modules for medical electronics manufacturers, including sensors and sub-assemblies (medical OEM components).
- Global distribution and support network serving hospitals, clinics, and healthcare providers in multiple regions (healthcare delivery support).
Show more
More About
Opto Circuits (India) Limited operates in the medical technology and healthcare equipment domain, providing devices and systems that are deployed across hospitals, critical-care units, emergency services, and home-care environments. Its portfolio spans non-invasive patient monitoring, cardiology and vascular intervention devices, and diagnostic equipment, giving enterprise healthcare buyers a single supplier across several device categories.
In enterprise and institutional settings, Opto Circuits’ non-invasive monitoring solutions (patient monitoring) are used for continuous or episodic measurement of vital parameters such as blood pressure, temperature, and related physiological signals. These devices are typically integrated into bedside monitoring stations, portable monitors for emergency medical services, and operating theatre environments. Architecturally, the equipment relies on standard biomedical sensor technologies, embedded electronics, and communication interfaces that allow interoperability with hospital information systems and electronic medical record platforms where supported.
The company’s cardiac and vascular devices (cardiovascular devices) target interventional cardiology and peripheral vascular procedures, with product lines that include stents and related devices used by catheterization labs and surgical teams. These offerings align with common interventional cardiology frameworks that depend on compatibility with established catheter systems, imaging modalities, and procedural protocols used in hospitals and specialty clinics. For procurement and clinical engineering teams, this places Opto Circuits in the same broad solution category as other suppliers of interventional cardiology hardware.
Opto Circuits also addresses home health and primary-care environments through diagnostic and monitoring products such as digital thermometers and blood pressure monitors (home health monitoring). These devices are used both by consumers and by clinicians in ambulatory or community-health contexts, and in some cases can be incorporated into remote monitoring workflows managed by healthcare providers. From an enterprise perspective, this supports population health and chronic-disease management programs that require standardized, reliable measurement tools at the edge of care delivery.
For OEM and B2B customers, Opto Circuits supplies components and sub-systems (medical OEM components) such as sensor modules that can be integrated into third-party medical devices. This supports device manufacturers that need pre-engineered biomedical sensing elements compliant with relevant medical-device norms. Within a technology taxonomy, the company’s offerings map to medical devices, patient monitoring, interventional cardiology hardware, home health diagnostics, and OEM medical electronics, making it relevant to hospital procurement, group purchasing organizations, and medical device manufacturers evaluating sourcing and integration options.
Our description of Opto Circuits (India) Limited. Updated February 2026.